P. Ljungman

发表

The role of hepatitis C and B virus infections as risk factors for severe liver complications following allogeneic BMT: a prospective study by the Infectious Disease Working Party of the European Blood and Marrow Transplantation Group.

A. Alberti, M. Valsecchi, P. Ljungman, 1999, Transplantation.

Hepatitis C virus genotypes and liver disease in patients undergoing allogeneic bone marrow transplantation

A. Alberti, P. Pontisso, P. Ljungman, 1997, Bone Marrow Transplantation.

Impact of liver disease and hepatitis infections on allogeneic bone marrow transplantation in Europe: a survey from the European Bone Marrow Transplantation (EBMT) Group--Infectious Diseases Working Party.

H. Einsele, A. Alberti, P. Ljungman, 1994, Bone marrow transplantation.

Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution

H. Nahi, P. Ljungman, M. Remberger, 2012, Medical Oncology.

Immunosuppressive CD14+HLA-DRlow/neg IDO+ myeloid cells in patients following allogeneic hematopoietic stem cell transplantation

D. Mougiakakos, R. Jitschin, P. Ljungman, 2013, Leukemia.

LONG‐TERM CYCLOSPORIN THERAPY MAY DECREASE THE RISK OF CHRONIC GRAFT‐VERSUS‐HOST DISEASE

P. Ljungman, O. Ringdén, B. Lönnqvist, 1990, British journal of haematology.

BK-viruria and haemorrhagic cystitis are more frequent in allogeneic haematopoietic stem cell transplant patients receiving full conditioning and unrelated-HLA-mismatched grafts

P. Ljungman, M. Remberger, O. Ringdén, 2008, Bone Marrow Transplantation.

Viral disease prevention after hematopoietic cell transplantation

H. Einsele, M. Boeckh, P. Ljungman, 2009, Bone Marrow Transplantation.

Unrelated-donor bone marrow transplantation for Philadelphia chromosome-positive chronic myelogenous leukemia in children: experience of eight European Countries. The EBMT Paediatric Diseases Working Party.

F. Locatelli, E. Lanino, T. Klingebiel, 1996, Bone marrow transplantation.

Cytomegalovirus infections in transplant patients.

P. Ljungman, P. Ljungman, 1996, Scandinavian journal of infectious diseases. Supplementum.

Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia

A. Gratwohl, P. Ljungman, K. Sobocinski, 1998, Bone Marrow Transplantation.

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

J. S. Daly, A. Casadevall, I. Sia, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cytomegalovirus in hematopoietic stem cell transplant recipients.

M. Boeckh, P. Ljungman, Morgan Hakki, 2010, Infectious disease clinics of North America.

Occupational status among adult survivors following allo-SCT

K. Alexanderson, A. Wennman-Larsen, P. Ljungman, 2014, Bone Marrow Transplantation.

High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients

V. Emery, P. Ljungman, M. Remberger, 2000, British journal of haematology.

High-dose chemotherapy with autologous stem cell support in patients with responding stage IV breast cancer

J. Bergh, G. Juliusson, M. Höglund, 1998, Bone Marrow Transplantation.

Incidence, risk factors, and outcome of bloodstream infections during the pre‐engraftment phase in 521 allogeneic hematopoietic stem cell transplantations

P. Ljungman, M. Remberger, J. Mattsson, 2014, Transplant infectious disease : an official journal of the Transplantation Society.

Oncologists and hematologists’ perceptions of fertility-related communication – a nationwide survey

C. Lampic, L. Wettergren, K. Rodriguez-Wallberg, 2017, Acta oncologica.

The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation

P. Ljungman, O. Ringdén, J. Aschan, 2003, Bone Marrow Transplantation.

Transmission of donor illness by stem cell transplantation: should screening be different in older donors?

A. Gratwohl, D. Niederwieser, P. Ljungman, 2004, Bone Marrow Transplantation.

Fresh or frozen grafts for allogeneic stem cell transplantation: conceptual considerations and a survey on the practice during the COVID-19 pandemic from the EBMT Infectious Diseases Working Party (IDWP) and Cellular Therapy & Immunobiology Working Party (CTIWP)

N. Knelange, R. de la Cámara, J. Hoogenboom, 2023, Bone Marrow Transplantation.

Late-onset keratoconjunctivitis sicca syndrome after bone marrow transplantation: incidence and risk factors. European Group or Blood and Marrow Transplantation (EBMT) Working Party on Late Effects.

A. Gratwohl, A. Tichelli, P. Ljungman, 1996, Bone marrow transplantation.

Pretransplant vaccinations in allogeneic stem cell transplantation donors and recipients: an often-missed opportunity for immunoprotection?

P. Ljungman, J. Styczyński, B. Savani, 2015, Bone Marrow Transplantation.

Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection

P. Ljungman, M. Remberger, O. Ringdén, 1998, Bone Marrow Transplantation.

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

G. Mufti, N. Kröger, M. Robin, 2017, Bone Marrow Transplantation.

Comparison of upfront tandem autologous–allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma

N. Kröger, S. Iacobelli, G. Gahrton, 2015, Bone Marrow Transplantation.

HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis

P. Ljungman, P. Lusso, E. Amirian, 2013, Bone Marrow Transplantation.

Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies.

P. Ljungman, M. Remberger, O. Ringdén, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term follow-up of the SBG 9401 study comparing tailored FEC-based therapy versus marrow-supported high-dose therapy.

J. Bergh, P. Malmström, H. Holte, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival

P. Ljungman, M. Remberger, O. Ringdén, 2008, Bone Marrow Transplantation.

Graft rejection and second bone marrow transplants for acquired aplastic anaemia: a report from the Aplastic Anaemia Working Party of the European Bone Marrow Transplant Group.

P. Ljungman, E. Gluckman, A. Bacigalupo, 1994, Bone marrow transplantation.

Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party

P. Ljungman, H. Schrezenmeier, E. Gluckman, 1993, British journal of haematology.

Long-term follow-up of a randomized trial comparing T-cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.

M. Remberger, O. Ringdén, B. Lönnqvist, 1994, Transplantation proceedings.

Quantification of adenovirus DNA in unrelated donor hematopoietic stem cell transplant recipients.

L. Engstrom, H. Omar, I. Gustafson, 2008, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.